Submissions

Login or Register to make a submission.

Author Guidelines

A. Manuscript submission

Authors should submit an electronic version in MS Word document of the manuscript to the Executive Editor via e-mail (jmomc2015@gmail.com) and two hard copies of the manuscript with a Cover letter including sequences and contributions of as well as signed by all authors (a sample ‘Cover letter’ below) to the address on right by surface mail or by hand:

B. Manuscript preparation for JMoMC

B.1. For manuscript preparation, the Journal of Monno Medical College (JMoMC) encourages authors to follow recommendations by the International Committee for Medical Journal Editors (ICMJE) (https://www.icmje.org/recommendations/).

B.2. Brief guidelines of manuscript preparation:

B.2.1. For Original Research articles- Limit within 3,000 words excluding abstract, up to 40 references, up to 6 tables and figures, notes and titles- that corresponds to a maximum of 5 printed pages of the JMoMC.  Divide the text into IMRAD (Introduction, Methods, Results and Discussion). However, authors can also add subheadings within these sections to further organize the contents.

Following are general formats of manuscript sections for all study designs and manuscript formats.

  1. Title page- Includes the article title, author information (full names of all authors with study-time affiliations), any disclaimers, source of support, word count and number of tables and figures.

Article title- Provides a clear description of the total article with no more than 40 characters including letters and spaces. The title should include key words that will make electronic retrieval of the article sensitive and specific.

Author information- Include full names of the authors with name of the department(s) and institution(s) or organization(s) where the work has been completed (to be attributed).

Provide full contact information, including land/surface mail, e-mail addresses and telephone number of the corresponding author.

Disclaimers- Include a statement that views expressed in the submitted article are his/her/their own and not an official position of the institution or funder.

Source(s) of support- Include grants, equipment, drugs and/or other support that facilitated completion of the work and/or writing the manuscript.

Word count- Provide word counts for abstract and the text excluding acknowledgements, tables, figure legends and references.

Number of tables and figures- Provide to ensure that all tables and figures are actually included with the manuscript.

  1. Abstract- The JMoMC requires ‘structured abstract’ within 250 words for manuscripts of Original research, Systematic reviews and Meta-analyses providing brief descriptions of the Background, Objectives, Methodology, Results and Conclusion of the study. Ensure that the abstract accurately reflect the content of the article and be careful that information in the abstract do not differ from that in the text.
  • Introduction- Provide a context or background for the study mentioning the nature of the problem (research question) and its significance. Cite only strictly pertinent references and do not include data or conclusions from the work being reported. Take care that all key words of the title have been elaborated from recent previous works and no important work has been omitted. State specific purpose or research objective of, or hypothesis tested by the study or observation.
  1. Methods- The JMoMC names this section as ‘Methodology’ and includes clarity about why and how the study was done with sufficient details to facilitate reproducibility. Give details about any funding that helped to conduct the research. Should include a statement that the research was approved by an independent local or national review body (i.e., Ethics committee or Institutional review board). Describe statistical methods with enough detail to enable knowledgeable reader to judge and verify reported results.
  2. Results- Present results in logical sequence in the text, tables and figures, giving the most important findings first. Do NOT repeat all the data in the table or figures in the text- emphasize or summarize only the important observations. Provide data on all primary and secondary outcomes identified in the Methods section. Give numeric results not only as ‘derivatives’ (e.g., percentages) but also as ‘absolute’ numbers from which the derivatives were calculated. Restrict tables and figures to those required to explain the argument. Use graphs as an alternative to tables with many entries- do NOT duplicate data in tables and graphs. Avoid non-technical use of technical terms in statistics (e.g., ‘random’, ‘normal’, ‘significant’, ‘sample’ etc). Separate reporting of data by demographic variables like age, sex etc.
  3. Discussion- Begin by briefly summarizing main findings and explore possible mechanisms or explanations for these findings. Emphasize new and important aspects of the study. State limitations of the study and explore implications for the findings of the study for future research and for clinical practice or policy. Discuss influence or association of variables on the findings and limitations of the data. Do NOT repeat in detail the data or other information given in other parts of the manuscript. Link conclusions with goals of the study, but avoid unqualified statements and conclusions not adequately supported by the data. Avoid claiming priority or alluding to work that has not been completed. State new hypothesis when warranted, but label them clearly.
  • References- Provide direct references to original research sources whenever possible. Designate references to papers accepted but not yet published as ‘in press’ or ‘forthcoming’. Avoid citing a ‘personal communication’ unless it is essential, in which case mention name of the person and date of communication in parenthesis in the text. Accuracy of all reference citations are not checked- authors are responsible for checking that none of the references cite retracted articles. Number references consecutively in the order in which they are first mentioned in the text. Identify references in texts, tables and legends by Arabic numerals in parenthesis (do NOT superscript them). Abbreviate titles of the journals according to the style used for MEDLINE (ncbi.nlm.nih.gov/nlmcatalog/journals).

Style and format- Follow NLM style (former Vancouver style) with examples in webpage (www.nlm.nih.gov/bsd/uniform_requirements.html) or detailed in NLM’s Citing Medicine, 2nd edition (www.ncbi.nlm.nih.gov/books/NBK7256/).

  • Tables- Prepare tables according to standard requirements. Include tables after ‘Reference’ section to supplement and not to duplicate the text in ‘Methodology’ or ‘Results’ sections. Number tables consecutively in the order of their first citation in text and supply a title for each. Title of the table should be short but self-explanatory, containing information that allows readers to understand the table’s content without going back to the text. Be sure that each table is cited in the text. Give each column a short or an abbreviated heading. Place explanatory matter in footnotes, not in the heading. Explain all non-standard abbreviations in footnotes and use symbols to explain information, if needed. For using data from another published or unpublished source, obtain permission and acknowledge that source fully.
  1. Illustrations (Figures)­- Should be either professionally drawn and photographed or submitted as photographic quality digital prints. For Radiological and other clinical/ diagnostic images as well as pictures of pathology specimens or photomicrographs, send high-resolution photographic image files. Figures should be made as self-explanatory as possible. Ensure titles and detailed explanations belong in the legends- not on the illustrations (figures) themselves. Number figures consecutively in the order as they been cited in the text. If a figure has been published previously, acknowledge the original source and submit written permission from the copyright holder to reproduce it. In the manuscript, legends for illustrations should be on a separate page, with Arabic numerals corresponding to illustrations.
  2. Units of measurement- Measurements of length, height, weight and volume should be in metric units (meter, kilogram or liter) or their decimal multiples. Temperatures should be in Celsius. Blood pressures should be in millimeters of Mercury.
  3. Abbreviations and symbols- Use only standard abbreviations. Avoid abbreviations in the ‘Title’ of the manuscript. The spelled-out abbreviation followed by the abbreviation in parenthesis should be used on first mention, unless the abbreviation is a standard unit of measurement.

B.2.2. For Case Reports- Limit within 2,000 words excluding up to 30 references and up to 4 tables and figures- corresponding a maximum of 3 printed pages of the JMoMC. Divide text into an abstract, an introduction, the case presentation, discussion and conclusion. For using identifiable pictures of patients, provide patient’s informed consent for this publication which includes his/her awareness of possible consequences after publication.

B.2.3. For Reviews- Limit within 4,000 words excluding up to 110 references and up to 6 tables and figures. Divide text into an abstract, an introduction that outlines the main themes, brief subheadings and/or an outline of important unresolved questions.

B.2.4. For Letters to Editor- Limit within 500 words excluding up to 5 references and up to 2 tables and figures- that corresponds to 1 printed page of the JMoMC.

C. Manuscripts management for JMoMC

C.1. Manuscript receive and management: Manuscripts are received throughout the year and a submitted manuscript is usually published and posted to the author within a highest of 9-months of submission. However, this timeline may be prolonged in cases of: (a) bad submission time (3-months before publication datelines (June and December each year), unless requested)); (b) bad preparation (not followed appropriately the JMoMC requirements), (c) bad responses (failing to respond within set timeline and response is inadequate).

C.2. Stages and timelines of Management

C.2.1. Stage 1: Editorial Scanning (usually completed in 1st month of submission)

  1. Received papers are entered into receive register giving an ID and acknowledged;
  2. Editorial scanning- checked for appropriateness, integrity and plagiarism;
  3. Primary author response- sent to corresponding author for primary response.

C.2.2. Stage 2: Peer Review (usually completed in 2nd month of submission)

  1. Processed for Peer reviews (select Peer(s), sent to reviewers with timeline);
  2. Sent to corresponding author for responses with a timeline;
  3. Cross-check by Editorial staff for accommodation of the review comments.

C.2.3. Stage 3: Decision of Acceptance/ Rejection (usually completed within 4th month of submission)

  1. Information of ‘Acceptance’/ ‘Rejection’ communicated with the corresponding author;
  2. Accepted papers are processed for Pre-Press version and submitted to Printing Press;
  3. Decisions of rejections of the submissions are made in cases of serious violation of publication ethics including plagiarism, allegations of misconduct pre- and post-publication, authorship dispute, undisclosed conflict(s) of interest, research misconduct (fabricated study and data falsification), unethical practice during research, and duplicate publication.
  • Stage 4: Publication (usually within 9th month of submission)
    1. Printed hard copies are distributed soon after publication (in no cost currently) to the faculty members of MoMC, Libraries of the BMDC-registered Medical/ Dental institutions in Bangladesh and the authors of the publications;
    2. Usually 3-copies of the published issue are sent for the authors of a publication to the address of communication of the corresponding author.

Copyright and Reprint permissions

The Journal of Monno Medical College (J Monno Med Coll) is an open access, peer-reviewed medical journal, published by Monno Medical College, Monno City, Gilondo, Manikganj, Bangladesh. The J Monno Med Coll is published twice yearly in June and December each year with a circulation of about 250 copies. The annual subscription rates are USD 50.00 plus postage for individuals and USD 100.00 plus postage for institutions overseas and Tk. 200.00 plus postage for local subscribers. In accordance with the Creative Commons Attribution License (CC BY-NC) (https://creativecommons.org/licenses4/), all copyrights© are reserved for J Monno Med Coll and the owner of the intellectual property to the particular author of the article. The data and the opinions expressed in the published articles are those of the author(s) and hold responsibility for all related events after publication. Contacts: Editor-in-Chief, Journal of Monno Medical College, Office of the Principal, Monno Medical College, Monno City, Gilondo, Manikganj, Bangladesh. E-mails: jmomc2015@gmail.com, jmomc@monnomch.edu.bd

Authors who publish in the Journal of Monno Medical College agree to the following terms that:

  1. Authors retain copyright and grant the Journal of Monno Medical College the right of first publication of the work.
  2. Creative Commons Licence
    Articles in the Journal of Monno Medical College are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). This license permits Share— copy and redistribute the material in any medium or format, adapt — remix, transform, and build upon the material as long as it is not for commercial purposes.

Submission Preparation Checklist

All submissions must meet the following requirements.

  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in OpenOffice, Microsoft Word, or RTF document file format.
  • Where available, URLs for the references have been provided.
  • The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.

Articles

Section default policy

Privacy Statement

Bangladesh Journals Online (BanglaJOL) is a member of the Ubiquity Partner Network coordinated by Ubiquity Press. According to the EU definitions, BanglaJOL is the data controller, and Ubiquity Press are the service providers and data processors. Ubiquity Press provide the technical platform and some publishing services to BanglaJOL and operate under the principle of data minimisation where only the minimal amount of personal data that is required to carry out a task is obtained.

More information on the type of data that is required can be found in Ubiquity Press’ privacy policy below.

Ubiquity Press Privacy Policy

We take seriously our duty to process your personal data in a fair and transparent way. We collect and manage user data according to the following Privacy Policy. This document is part of our Terms of Service, and by using the press portal, affiliated journals, book, conference and repository websites (the “Websites”), you agree to the terms of this Privacy Policy and the Terms of Service. Please read the Terms of Service in their entirety, and refer to those for definitions and contacts.

What type of personal data do we handle?

There are four main categories of personal data stored by our journal platform, our press platform, and our book management system; Website User data, Author data, Reviewer data and Editor data.

The minimum personal data that are stored are:

  • full name
  • email address
  • affiliation (department, and institution)
  • country of residence

Optionally, the user can provide:

  • salutation
  • gender
  • associated URL
  • phone number
  • fax number
  • reviewing interests
  • mailing address
  • ORCiD
  • a short biography
  • interests
  • Twitter profile
  • LinkedIn profile
  • ImpactStory profile
  • profile picture

The data subjects have complete control of this data through their profile, and can request for it to be removed by contacting info@ubiquitypress.com

What do we do to keep that data secure?

We regularly backup our databases, and we use reliable cloud service providers (Amazon, Google Cloud, Linode) to ensure they are kept securely. Backups are regularly rotated and the old data is permanently deleted. We have a clear internal data handling policy, restricting access to the data and backups to key employees only. In case of a data breach, we will report the breach to the affected users, and to the press/journal contacts within 72 hours.

How do we use the data?

Personal information is only used to deliver the services provided by the publisher. Personal data is not shared externally except for author names, affiliations, emails, and links to ORCiD and social media accounts (if provided) in published articles and books which are displayed as part of the article/book and shared externally to indexes and databases. If a journal operates under open peer review then the reviewer details are published alongside the reviewer details.

How we collect and use your data:

1. When using the website

1.1 what data we collect

  • When you browse our website, we collect anonymised data about your use of the website; for example, we collect information about which pages you view, which files you download, what browser you are using, and when you were using the site.
  • When you comment on an article or book using Disqus, we are not collecting, controlling or processing the data. More details on the DISQUS privacy policy can be found on their website.
  • When you annotate an article or book, this is done via a 3rd party plugin to the website called Hypothes.is. In using this plugin we are not collecting, controlling or processing the data. More details on the Hypothes.is privacy policy can be found on their website.

1.2 why we collect the data

  • We use anonymised website usage data to monitor traffic, help fix bugs, and see overall patterns that inform future redesigns of the website, and provide reports on how frequently the publications on our site have been accessed from within their IP ranges.

1.3 what we do (and don’t do) with the data

  • We do not collect personal information that can be used to identify you when you browse the website.
  • We currently use Google Analytics for publication reports, and to improve the website and services through traffic analysis, but no personal identifying data is shared with Google (for example your computer’s IP is anonymised before transmission).

1.4 what to do if you want to get a copy of your data, or want your data to be removed

  • Please contact info@ubiquitypress.com to request a copy of your data, or for your data to be removed/anonymised.

2. When registering as an author, and submitting an article or book

2.1 what data we collect

  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • As part of submitting an article for publication, you will need to provide personally identifying information which will be used for the peer review process, and will be published. This can include ‘Affiliation’, ‘Competing interests’, ‘Acknowledgements’.

2.2 why we collect the data

  • Registering an account allows you to log in, manage your profile, and participate as an author/reviewer/editor. We use cookies and session information to streamline your use of the website (for example in order for you to remain logged-in when you return to a journal). You can block or delete cookies and still be able to use the websites, although if you do you will then need to enter your username and password to login. In order to take advantage of certain features of the websites, you may also choose to provide us with other personal information, such as your ORCiD, but your decision to utilize these features and provide such data will always be voluntary.
  • Personal data submitted with the article or book is collected to allow follow good publication ethics during the review process, and will form part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.3 what we do (and don’t do) with the data

  • We do not share your personal information with third parties, other than as part of providing the publishing service.
  • As a registered author in the system you may be contacted by the journal editor to submit another article.
  • Any books published on the platform are freely available to download from the publisher website in PDF, EPUB and MOBI formats on the publisher’s site.
  • Any personal data accompanying an article or a book (that will have been added by the submitting author) is published alongside it. The published data includes the names, affiliations and email addresses of all authors.
  • Any articles published on the platform are freely available to download from the publisher website in various formats (e.g. PDF, XML).
  • Ubiquity Press books and articles are typeset by SiliconChips and Diacritech.This process involves them receiving the book and book associated metadata and contacting the authors to finalise the layout. Ubiquity Press work with these suppliers to ensure that personal data is only used for the purposes of typesetting and proofing.
  • For physical purchases of books on the platform Ubiquity Press use print on demand services via Lightning Source who are responsible for printing and distribution via retailers. (For example; Amazon, Book Repository, Waterstones). Lightning Source’s privacy policy and details on data handling can be found on their website.

2.4 why we store the data

  • We store the account data so that you may choose to become a reviewer and be able to perform those tasks, or to become an author and submit an article and then track progress of that article.
  • Published personal data that accompanies an article or a book forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.5 what to do if you want to get a copy of your data, or want your data to be removed

  • You are able to view, change and remove your data associated with your profile. Should you choose to completely delete your account, please contact us at support@ubiquitypress.com and we will follow up with your request as soon as possible.
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

3. When registering as a reviewer

3.1 what data we collect

  • To become a reviewer you must first register as a user on the website, and set your preference that you would like to be considered as a reviewer. No new personal data is collected when a registered user elects to become a reviewer.
  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • Reviewers can also be registered by editors who invite them to review a specific article. This requires the editor to provide the reviewer’s First Name, Last Name, and Email address. Normally this will be done as part of the process of inviting you to review the article or book.
  • On submitting a review, the reviewer includes a competing interest statement, they may answer questions about the quality of the article, and they will submit their recommendation.

3.2 why we collect the data

  • The data entered is used to invite the reviewer to peer review the article or book, and to contact the reviewer during and the review process.
  • If you submit a review then the details of your review, including your recommendation, your responses to any review form, your free-form responses, your competing interests statement, and any cover letter are recorded.

3.3 what we do (and don’t do) with the data

  • This data is not shared publicly and is only accessible by the Editor and system administrators of that journal or press.
  • The data will only be used in connection with that journal or press.
  • Data that is retained post final decision is kept to conform to publication ethics and best practice, to provide evidence of peer review, and to resolve any disputes relating to the peer review of the article or book.
  • For journals or presses that publish the peer reviews, you will be asked to give consent to your review being published, and a subset of the data you have submitted will become part of the published record.

3.4 what to do if you want to get a copy of your data, or want your data to be removed

  • If you would no longer like to be registered as a reviewer you can edit your profile and tick the box ‘stop being a reviewer’. This will remove you from the reviewer database, however any existing reviews you may have carried out will remain.
  • If you have been contacted by an editor to peer review an article this means that you have been registered in the system. If you would not like to be contacted for peer review you can reply to the email requesting that your data be deleted.

4. When being registered as a co-author

4.1 what data we collect

  • Co-author data is entered by the submitting author. The submitting author will already have a user account. According to standard publishing practice, the submitting author is responsible for obtaining the consent of their co-authors to be included (including having their personal data included) in the article/book being submitted to the journal/press.
  • The requested personal data for co-authors are at the bare minimum; first name, last name, institution, country, email address. This can also include; ORCID ID, Title, Middle Name, Biographical Statement, Department, Twitter Handle, Linkedin Profile Name or ImpactStory ID.

4.2 why we collect the data

  • Assuming that it is accepted for publication, this data forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.
  • Author names, affiliations and emails are required for publication and will become part of the permanent cited record.

4.3 what we do (and don’t do) with the data

  • The co-author’s personal data is stored in the author database. This personal data is only used in relation to the publication of the associated article.
  • Any co-author data collected is added to the author database and is only used in association with the article the user is co-author on.

4.5 what to do if you want to get a copy of your data, or want your data to be removed

  • To receive a copy of your data, please contact info@ubiquitypress.com
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

5. When signing-up to receive newsletters

5.1 what data we collect

  • We require you to include your name and email address

5.2 why we collect and store the data, and for how long

  • This data would be collected to keep you updated with any news about the platform or specific journal

5.3 what we do (and don’t do) with the data

  • We use mailchimp to provide our mailing list services. Their privacy policy can be found here

5.4 what to do if you want to get a copy of your data or want your data to be removed

  • All emails sent via our newsletter client will include a link that will allow you to unsubscribe from the mailing list

Notification about change of ownership or of control of data

We may choose to buy or sell assets. In the case that control of data changes to or from Ubiquity Press and a third party, or in the case of change of ownership of Ubiquity Press or of part of the business where the control of personal data is transferred, we will do our best to inform all affected users and present the options.

(Updated: 25 February 2020)